Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic–ischaemic encephalopathy: a nested substudy of a randomised controlled trial  by Rutherford, Mary et al.
www.thelancet.com/neurology   Vol 9   January 2010 39
Articles
Assessment of brain tissue injury after moderate hypothermia 
in neonates with hypoxic–ischaemic encephalopathy: a nested 
substudy of a randomised controlled trial
Mary Rutherford, Luca A Ramenghi, A David Edwards, Peter Brocklehurst, Henry Halliday, Malcolm Levene, Brenda Strohm, Marianne Thoresen, 
Andrew Whitelaw, Denis Azzopardi
Summary 
Background Moderate hypothermia in neonates with hypoxic–ischaemic encephalopathy might improve survival 
and neurological outcomes at up to 18 months of age, although complete neurological assessment at this age is 
diﬃ  cult. To ascertain more precisely the eﬀ ect of therapeutic hypothermia on neonatal cerebral injury, we assessed 
cerebral lesions on MRI scans of infants who participated in the Total Body Hypothermia for Neonatal 
Encephalopathy (TOBY) trial. 
Methods In the TOBY trial hypoxic–ischaemic encephalopathy was graded clinically according to the changes seen on 
amplitude integrated EEG, and infants were randomly assigned to intensive care with or without cooling by central 
telephone randomisation. The relation between allocation to hypothermia or normothermia and cerebral lesions was 
assessed by logistic regression with perinatal factors as covariates, and adjusted odds ratios (ORs) were calculated. 
The TOBY trial is registered, number ISRCTN 89547571.
Findings 325 infants were recruited in the TOBY trial between 2002 and 2006. Images were available for analysis from 
131 infants. Therapeutic hypothermia was associated with a reduction in lesions in the basal ganglia or thalamus (OR 
0·36, 95% CI 0·15–0·84; p=0·02), white matter (0·30, 0·12–0·77; p=0·01), and abnormal posterior limb of the 
internal capsule (0·38, 0·17–0·85; p=0·02). Compared with non-cooled infants, cooled infants had fewer scans that 
were predictive of later neuromotor abnormalities (0·41, 0·18–0·91; p=0·03) and were more likely to have normal 
scans (2·81, 1·13–6·93; p=0·03). The accuracy of prediction by MRI of death or disability to 18 months of age was 
0·84 (0·74–0·94) in the cooled group and 0·81 (0·71–0·91) in the non-cooled group. 
Interpretation Therapeutic hypothermia decreases brain tissue injury in infants with hypoxic–ischaemic 
encephalopathy. The predictive value of MRI for subsequent neurological impairment is not aﬀ ected by therapeutic 
hypothermia. 
Funding UK Medical Research Council; UK Department of Health.
Introduction 
Hypoxic–ischaemic encephalopathy after perinatal 
asphyxia is an important cause of mortality and morbidity 
in newborns that accounts for about 20% of occurrences 
of cerebral palsy in childhood.1,2 Although antenatal factors 
have been implicated in the aetiology of hypoxic–ischaemic 
encephalopathy, little evidence of antenatal injury is seen 
on early MRI scans in neonates that present with 
hypoxic–ischaemic encephalopathy.1,3,4 Hypoxic–ischaemic 
encephalopathy can be graded on clinical grounds or 
according to the changes seen on amplitude integrated 
EEG.5,6 The main neurodevelopmental sequela to moderate 
or severe hypoxic–ischaemic encephalopathy is severe 
neuromotor impairment, but cognitive and other 
impairments can also occur.7–9 
Until recently, there were no speciﬁ c treatments for 
hypoxic–ischaemic encephalopathy. The results of 
randomised controlled trials of 72 h of selective head or 
whole-body cooling started within 6 h of birth have 
suggested improved neurological outcomes up to 
18 months of age, and treatment with hypothermia is 
increasingly used clinically.10–13 Because neurological 
assessment at 18 months of age is diﬃ  cult, other signs of 
the therapeutic eﬃ  cacy of cooling would strengthen the 
evidence base for the treatment of hypoxic–ischaemic 
encephalopathy.
MRI is the optimum technique to detect perinatally 
acquired cerebral lesions, and the pattern and severity of 
the lesions provide a reliable guide to prognosis.14–20 In 
the presence of a sentinel event consistent with a severe 
acute hypoxic–ischaemic insult, lesions in the basal 
ganglia and thalami are often associated with 
abnormalities in speciﬁ c cortical regions and in the 
adjacent subcortical white matter.4 Abnormal signal 
intensity in the posterior limb of the internal capsule 
coexists with lesions in the basal ganglia and thalami and 
is a powerful predictor of abnormal motor outcome.14 
Lesions in the basal ganglia and thalami are often 
associated with abnormalities in speciﬁ c cortical regions 
and the adjacent subcortical white matter after an event 
that is consistent with a severe acute hypoxic–ischaemic 
insult.17 Moderate and severe lesions in the basal ganglia 
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and thalami and severe white matter lesions are 
associated with cerebral palsy.4, 20,21 
In the Total Body Hypothermia for Neonatal 
Encephalopathy (TOBY) trial, infants who were allocated 
to prolonged moderate hypothermia showed no signiﬁ cant 
diﬀ erence in the primary outcome of death or disability at 
18 months but had a reduced rate of cerebral palsy and 
improved mental and psychomotor outcomes compared 
with those allocated to standard care.12 We hypothesised 
that whole-body cooling would be associated with a 
reduction in cerebral lesions seen on MRI that are 
characteristic of hypoxic–ischaemic encephalopathy, 
including lesions that predict later neurodevelopmental 
impairments, and that cooling would not alter the 
accuracy of neonatal MRI for predicting neurological 
outcome at 18 months of age. To test this hypothesis, we 
reviewed the MRI scans obtained during the neonatal 
period in a nested substudy of the TOBY trial.
Methods
Patients
Infants born after 36 or more completed weeks’ gestation 
who showed signs of moderate or severe encephalopathy, 
with or without seizures, were assessed with amplitude 
integrated EEG.12 Infants were randomly assigned, by 
central telephone randomisation within 6 h of birth, to a 
control group (rectal temperature kept to within 0·2°C of 
37°C) or to whole-body cooling (rectal temperature kept 
at 33–34°C for 72 h). Mode of delivery, gestational age, 
sex, birthweight, Apgar score, occipitofrontal head 
circumference at birth, cooling status, and age at MRI 
scan were recorded.
The primary outcome of the TOBY trial was death or 
severe neurodisability at 18 months, which was deﬁ ned as 
at least one from: mental development index (MDI) less 
than 70 (2 or more SD below the mean) on the Bayley 
infant scales (BSID II);22 a level of 3–5 on the gross motor 
function classiﬁ cation system (GMFCS), which ranges 
from 1 to 5, with 1 being the mildest impairment;23,24 or 
bilateral cortical visual impairment with no useful vision. 
The TOBY trial is registered, number ISRCTN 
89547571, and was approved by the London Multicentre 
Research Ethics Committee and the local research ethics 
committee of each participating hospital. Written 
informed consent was obtained from one parent of each 
infant that participated in the trial. 
Procedures
Neonates were imaged with conventional T1-weighted and 
T2-weighted sequences at 1·5 T or 3 T. Images were 
included if they were acquired within the ﬁ rst 4 weeks after 
birth—the optimum period in which to image brain 
lesions that occurred around the time of birth.16 Two 
independent experts who were masked to treatment 
allocation reviewed the images for quality, normal anatomy, 
and acquired lesions. Images that were deemed to be of 
inadequate quality were not analysed further. The reviewers 
classiﬁ ed all images independently before the results were 
compared, and the inter-observer variability was estimated; 
cases of disagreement were resolved by consensus. 
A diagnosis of venous sinus thrombosis was made if 
abnormal signal intensity was seen in a major venous 
sinus and was associated with lesions that were consistent 
with haemorrhagic venous infarction in the draining 
territory of the sinus. Subdural haemorrhage was 
classiﬁ ed as mild, moderate, or severe. The pattern of 
injury was classiﬁ ed according to the abnormal ities seen, 
as previously described (webappendix).17 Moderate or 
severe lesions in the basal ganglia and thalamus, an 
abnormal posterior limb of the internal capsule, or severe 
white matter lesions were deemed to be predictive of 
abnormal neurodevelopmental outcome (ﬁ gure 1). 
Statistical analysis
Data were analysed with SPSS version 16 (SPSS, IL, 
USA). Clinical characteristics between groups were 
compared by χ² for categorical data and t test or Mann-
Whitney test, as appropriate, for continuous data. The 
relations among sex, gestational age, postnatal age at 
scan, Apgar score, severity of hypoxic–ischaemic 
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Figure 1: MRI appearances in neonatal hypoxic–ischaemic encephalopathy
(A-C) T1-weighted images in the transverse plane. (A) Normal neonatal brain with linear high signal intensity 
representing myelin in the posterior limb of the internal capsule (arrow). (B) Moderate basal ganglia and thalamic 
lesions with abnormal increased signal intensity in the globus (top arrow), putamen (middle arrow), and thalamus 
(bottom arrow). There is no normal linear high signal intensity from the intervening posterior limb of the internal 
capsule. (C) Cortical lesions. There is abnormal increased signal intensity in the cortex around the central sulcus 
(arrow head) and along the interhemispheric ﬁ ssure. Abnormal low signal intensity is seen in the adjacent 
subcortical white matter (arrow). (D–F) T2-weighted images in the transverse plane. (D) Mild lesions in the basal 
ganglia. There are small bilateral foci of abnormal low signal intensity in the lentiform nuclei (arrow). (E) Mild 
white matter lesions. There is diﬀ use and slightly increased signal intensity in the periventricular white matter 
(arrow). (F) Severe basal ganglia and thalamic and white matter lesions. There is mixed abnormal signal intensity 
throughout the basal ganglia and thalami. The intervening posterior limb of the internal capsule shows abnormal 
high signal intensity with no evidence of low signal intensity from myelin (arrow). The hemispheric white matter 
has diﬀ use abnormal high signal intensity throughout. 
See Online for webappendix
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encephalopathy seen on amplitude integrated EEG, 
treatment allocation, and cerebral lesions seen on MRI 
were assessed by univariate analysis. Logistic regression 
and calculation of adjusted odds ratios (adjusted OR, 
95% CI) were done to assess the eﬀ ect of cooling on 
cerebral lesions seen on MRI, controlling for the perinatal 
factors that were signiﬁ cant on univariate analysis. 
Two-sided p values less than 0·05 were regarded as 
signiﬁ cant.
The ability of MRI to predict an abnormal outcome, 
deﬁ ned as death or severe disability at 18 months of age, 
was assessed for both cooled and non-cooled infants by 
calculation of the predictive accuracy, sensitivity, 
speciﬁ city, and positive and negative predictive values.
Role of funding source
The study sponsors had no role in the study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit the paper for publication. 
Results 
325 infants were recruited to the TOBY trial between 
2002 and 2006. MRI scans were obtained from 151 infants 
from the 22 hospitals with facilities for neonatal MRI. 
Figure 2 shows the study proﬁ le. 12 (seven cooled, ﬁ ve 
non-cooled) of the 151 sets of images were unsuitable for 
analysis. One infant who had an overt pontocerebellar 
hypoplasia seen on MRI was excluded from further 
analysis. MRIs from three cooled and four non-cooled 
infants were taken post mortem, and these images were 
not included. Therefore, images were available for 
analysis for 131 infants: 64 in the group allocated to 
cooling and 67 infants in the non-cooling group. There 
was no diﬀ erence in gestational age or birthweight 
between the two groups. The cooled infants had similar 
10-min Apgar scores and there was no diﬀ erence in the 
severity of amplitude integrated EEG between the two 
groups (p=0·32; table 1). The clinical characteristics of 
these 131 infants were not diﬀ erent from the rest of the 
infants in the TOBY trial, although there were more 
severely abnormal amplitude integrated EEG ﬁ ndings in 
infants that were not included in the substudy 
(webappendix).
The median age at postnatal scan was 8 days 
(range 2–30) in both groups and all infants were older 
than 37 weeks gestational age at the time of scan. 
Observer agreement for classiﬁ cation of MRI scans was 
greater than 99%. None of the patterns of injury were 
deemed to be unusual for patients with hypoxic–ischaemic 
encephalopathy. 
On univariate analysis, treatment allocation was 
signiﬁ cantly associated with abnormal MRI in the basal 
ganglia and thalami (p=0·01), white matter (p=0·01), and 
the posterior limb of the internal capsule (p=0·03); there 
was an improvement of trend across categories of severity 
of MRI abnormalities in the basal ganglia and thalami 
(p=0·02) and white matter (p=0·02) in the cooled group 
compared with the non-cooled group. Postnatal age at 
scan was signiﬁ cantly associated with abnormalities in 
the basal ganglia and thalami when examined as a 
continuous variable (p=0·02) or categorised into less 
than 8 days or 8 or more days (p=0·01), but did not 
correlate with abnormalities in the white matter or cortex. 
The amplitude integrated EEG grade correlated with 
abnormalities in the basal ganglia and thalami (p=0·001), 
white matter (p=0·003), and posterior limb of the internal 
capsule (p<0·0001). Postnatal age at scan and grade of 
amplitude integrated EEG were included as covariates in 
all the binomial logistic regression analyses of treatment 
allocation and MRI ﬁ ndings (table 2).
Lesions in the basal ganglia and thalami were detected 
in 38 of 64 (59%) cooled infants and 53 of 67 (79%) 
non-cooled infants (adjusted OR 0·36, 95% CI 0·15–0·84; 
p=0·02, table 2). The posterior limb of the internal 
capsule was normal in 34 of 64 (53%) cooled infants and 
MRI scans obtained from 151 newborns 
included in the TOBY trial (n=325)
131 included in nested substudy
67 received intensive care without cooling 64 received intensive care with cooling
11 had died at 18 months
22 had severe disability at 18 months
6 had died at 18 months
19 had severe disability at 18 months
 12 MRIs unsuitable for analysis
 1 infant had pontocerebellar hypoplasia 
  and was excluded
 7 MRIs taken post mortem excluded
Figure 2: Study proﬁ le
Cooled (n=64) Non-cooled (n=67) p
Gestational age (weeks) 40 (39–41) 40 (39–41) 0·73
Birthweight (g) 3450 (2995–3863) 3290 (3075–3736) 0·30
Occipitofrontal circumference at birth (cm) 35·3 (34·1–36·1) 35 (34·1–35·6) 0·61
Boys:girls 39:25 35:32 0·32
Apgar score at 10 min 4 (3–5) 4 (3–5) 0·36
Complications during delivery 48 (75%) 51 (76%) 0·76
Amplitude integrated EEG
Moderately abnormal 27 (42%) 34 (51%) 0·32*
Severely abnormal 35 (55%) 31 (46%)
Age at postnatal scan (days) 8 (6–11) 8 (5–10) 0·27
Data are median (IQR) or n (%). Amplitude integrated EEG was not available for two infants in each group. *χ² test 
for the proportion of moderately abnormal to severely abnormal amplitude integrated EEG in cooled (27:35) and 
non-cooled (34:31) groups.
Table 1: Clinical characteristics of the infants
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23 of 67 (34%) non-cooled infants, equivocal in two of 
64 (3%) cooled infants and ﬁ ve of 67 (7%) non-cooled 
infants, and abnormal in 28 of 64 (44%) cooled infants 
and 39 of 67 (58%) non-cooled infants (0·38, 0·17–0·85; 
p=0·02). White matter abnormalities were seen in 41 of 
64 (64%) cooled infants and 56 of 67 (84%) non-cooled 
infants (0·30, 0·12–0·77; p=0·01). Cortical abnormalities 
were seen in 30 of 64 (47%) cooled infants and 42 of 66 
(64%) non-cooled infants (0·62, 0·27–1·41; p=0·25).
Lesions that predicted abnormal neurodevelopmental 
outcome (deﬁ ned as at least one of: moderate or severe 
lesions in the basal ganglia and thalami [grade 2 or 3], an 
abnormal posterior limb of the internal capsule, or severe 
white matter abnormalities [grade 3]) were seen in 29 of 
64 (45%) cooled infants and 42 of 67 (63%) non-cooled 
infants (adjusted OR 0·42, 95% CI 0·20–0·92; p=0·03). 
22 of 64 (34%) cooled infants and 11 of 67 (16%) non-cooled 
infants had normal scans (2·81, 1·13–6·93; p=0·03). 
Logistic regression analysis showed that, in addition to 
treatment allocation, grade of amplitude integrated EEG 
was associated with abnormalities in the basal ganglia 
and thalami, white matter, and posterior limb of the 
internal capsule (all p<0·0001); major abnormalities that 
predicted abnormal outcome (p<0·0001); and normal 
scans (p=0·001). 37 of 59 (63%) infants scanned at less 
than 8 days of age had major abnormalities on MRI that 
were predictive of abnormal outcome compared with 
34 of 72 (47%) infants scanned later (p=0·08; table 3). 
After adjustment for grade of amplitude integrated EEG 
and treatment allocation in infants scanned at less than 
8 days of age compared with those scanned later, the 
OR for the detection of major abnormalities seen on MRI 
was 2·35 (1·07–5·14; p=0·03). 
Three infants (two cooled and one non-cooled) had 
evidence of sinus thrombosis and 47 (36%) had evidence 
of haemorrhage: 25 from the cooled group and 22 from 
the non-cooled group. The haemorrhage was subdural in 
39 infants, moderate in ten infants, and mild in 
29 infants. 
Assessment of the primary outcome was available for 
all but one infant. Of 130 infants, six cooled and 
11 non-cooled infants died (p=0·23), whereas 19 cooled 
and 22 non-cooled infants had severe disability at 
18 months of age (p=0·70; table 3). In the main TOBY 
trial,12 the rates of death were 42 of 163 (0·26) in the 
cooled group and 44 of 162 (0·27) in the non-cooled 
group. The rates for severe disability in survivors were 32 
of 120 (0·27) in the cooled group and 42 of 117 (0·36) in 
the non-cooled group. 
In this subset, all 17 infants who died and 36 of 41 (88%) 
infants with severe disability had moderate or severe 
lesions in the basal ganglia and thalami and an abnormal 
posterior limb of the internal capsule. Four of the 
remaining ﬁ ve infants who were classiﬁ ed as having 
severe disability had mild lesions in the basal ganglia and 
thalami and mild or normal white matter; the other 
infant had normal basal ganglia and thalamus but 
moderate lesions in the white matter. These ﬁ ve infants 
had an MDI less than 70 but a psychomotor developmental 
index (PDI) greater than 70. Four of the ﬁ ve infants had a 
GMFCS of 1 (the mildest level of impairment). 
11 infants with moderate lesions and two infants with 
severe lesions in the basal ganglia and thalami did not 
have severe disability at 18 months. An abnormal 
posterior limb of the internal capsule was seen in 11 of 
13 infants. These 13 infants had a PDI and MDI greater 
than 70, but ﬁ ve had a GMFCS of 1. All 34 infants 
(22 cooled, 12 non-cooled) with normal basal ganglia and 
thalami and normal or mild lesions in the white matter 
had a normal neuromotor outcome at 18 months. 
The predictive accuracy of moderate or severe lesions 
in the basal ganglia and thalami, severe white matter 
lesions, or an abnormal posterior limb of the internal 
capsule for death or severe disability at 18 months of age 
was 0·84 (95% CI 0·74–0·94 [53 of 63]) in the cooled 
group and 0·81 (0·71–0·91 [54 of 67]) in the non-cooled 
group (table 4).
Discussion 
We report brain MRI ﬁ ndings from a subgroup of infants 
enrolled in a randomised controlled trial of therapeutic 
hypothermia in neonates with hypoxic–ischaemic 
encephalo pathy. Therapeutic hypothermia was associated 
Cooled 
(n=64)
Non-cooled 
(n=67)
Adjusted* Unadjusted* 
OR (95% CI) p OR (95% CI) p
Basal ganglia and thalami
0 26 14 0·36 (0·15–0·84) 0·02 0·39 (0·18–0·84) 0·02
1 11 14
2 11 14
3 16 25
Posterior limb of internal capsule
Normal 34 23 0·38 (0·17–0·85) 0·02 0·46 (0·23–0·93) 0·03
Equivocal 2 5
Abnormal 28 39
White matter
Normal 23 11 0·30 (0·12–0·77) 0·01 0·35 (0·15–0·80) 0·01
1 19 26
2 15 21
3 7 9
Cortex†
0 34 24 0·62 (0·27–1·41) 0·25 0·65 (0·29–1·42) 0·28
1 16 22
2 10 16
3 4 4
Intracranial 
haemorrhage
25 22 Not done 1·31 (0·64–2·68) 0·11
Data are number or OR (95% CI).*Odds ratio for presence or absence of MRI abnormalities in cooled and non-cooled 
infants, with and without adjustment for severity of amplitude integrated EEG and postnatal age. OR=odds ratio. 
†Cortex could not be assessed in one infant in the non-cooled group. 
Table 2: Grades of cerebral lesions seen on MRI in cooled and non-cooled infants
Articles
www.thelancet.com/neurology   Vol 9   January 2010 43
with less grey and white matter abnormalities, and more 
cooled than non-cooled infants had normal MRI scans. 
The accuracy of MRI done during the neonatal period for 
the prediction of neurological outcomes up to 18 months 
of age was unaltered by therapeutic hypothermia. In this 
large cohort of infants who had an MRI after hypoxic–
ischaemic encephalopathy, we found no unusual patterns 
of lesions and no increase in haemorrhagic or thrombotic 
lesions associated with therapeutic hypothermia. 
These results are likely to be reliable because the clinical 
characteristics of the study infants were not diﬀ erent 
from the other infants in the TOBY trial; almost all infants 
(87% [131 of 151]) in TOBY who had MRI were included in 
the analysis; perinatal factors were similarly distributed 
among those allocated to therapeutic hypothermia or 
normothermia; and perinatal factors that were associated 
with MRI were included in a logistic analysis to assess 
any independent eﬀ ect of therapeutic hypothermia. The 
ORs for predicting MRI abnormalities by treatment 
allocation were not signiﬁ cantly diﬀ erent from those 
calculated by univariate analysis (table 2). 
As expected, the mortality rate in the study infants was 
less than that in the TOBY trial because many deaths 
occurred before MRI could be done, which is also likely 
to be the case in clinical practice. These diﬀ erences do 
not alter the study results because the mortality rate did 
not diﬀ er signiﬁ cantly between the cooled and non-cooled 
infants and was similar to the results of the main TOBY 
trial; furthermore, mortality was included in the 
assessment of the prognostic accuracy of MRI. 
Systematic reviews of randomised trials have shown 
improved survival and neurological outcomes after 
therapeutic hypothermia in newborns with hypoxic–
ischaemic encephalopathy.25 However, only three trials 
have reported outcomes to 18 months of age and the 
study design and outcomes diﬀ ered among the trials: the 
selective head cooling with mild systemic hypothermia 
after neonatal encephalopathy trial (the Coolcap trial)11 
used selective head cooling with mild whole-body cooling, 
whereas the whole-body hypothermia for neonates with 
hypoxic–ischaemic encephalopathy trial (the NICHD 
trial)12 and the TOBY trial used whole-body cooling. Only 
the NICHD trial showed a signiﬁ cant reduction in the 
primary outcome of the combined rates of death and 
disability. The ﬁ nding of a reduction in cerebral lesions 
on MRI that are associated with subsequent 
neurodevelopmental abnormalities and a higher rate of 
normal scans in cooled compared with non-cooled 
infants strengthens the evidence for the neuroprotective 
eﬃ  cacy of prolonged moderate hypothermia in newborns 
with hypoxic–ischaemic encephalopathy. 
Two observational studies have assessed MRIs of 
infants treated with hypothermia after hypoxic–ischaemic 
encephalopathy, although neither study controlled for 
perinatal factors that might aﬀ ect ﬁ ndings on MRI.26,27 In 
one non-randomised study of hypoxic–ischaemic 
encephalopathy in 34 infants treated with either head 
cooling or whole-body cooling and 52 non-cooled infants, 
there was a reduction in the incidence of moderate and 
severe lesions in the basal ganglia and thalami with 
cooling but this was only signiﬁ cant in infants with an 
early moderately abnormal amplitude integrated EEG.27 
Fewer cortical abnormalities were seen in the head-
cooling group but not in the group treated with 
whole-body cooling. In another study of 26 infants, 
whole-body cooling was associated with fewer cortical 
abnormalities than in the controls, suggesting a 
preferential eﬀ ect of cooling on the cortex.26 However, in 
our study cooling was associated with signiﬁ cant 
reductions in abnormalities in the basal ganglia and 
Cooled Non-cooled
Sensitivity 0·88 (0·79–0·97) 0·94 (0·88–1·0)
Speciﬁ city 0·82 (0·72–0·92) 0·68 (0·56–0·80)
Positive predictive value 0·76 (0·65–0·87) 0·74 (0·63–0·85)
Negative predictive value 0·91 (0·83–0·99) 0·92 (0·85–0·99)
Data are proportions (95% CI). Major MRI abnormalities were deﬁ ned as 
moderate or severe basal ganglia or thalamic lesions, severe white matter lesions, 
or an abnormal posterior limb of the internal capsule.
Table 4: Predictive ability of major MRI abnormalities during ﬁ rst 4 weeks 
after birth for death or severe disability at 18 months
Cooled* 
(n=63)
Non-cooled 
(n=67)
Total
<8 days
MRI abnormalities absent
Not disabled 10 11 21
Died or disabled 0 1 1
Total 10 12 22
MRI abnormalities present
Not disabled 1 7 8
Died or disabled 16 13 29
Total 17 20 37
≥8 days
MRI abnormalities absent
Not disabled 21 12 33
Died or disabled 3 1 4
Total 24 13 37
MRI abnormalities present
Not disabled 6 4 10
Died or disabled 6 18 24
Total 12 22 34
Data are number of infants. Major MRI abnormalities were deﬁ ned as moderate or 
severe basal ganglia or thalamic lesions, severe white matter lesions, or abnormal 
posterior limb of the internal capsule. Severe disability was deﬁ ned as at least one 
of the following: mental development index (MDI) score less than 70 (≥2 SD 
below the mean) on the Bayley Infant Scales (BSID II); score of 3–5 on the gross 
motor function classiﬁ cation system (GMFCS), which ranges from 1 to 5, with 
1 being the mildest impairment; or bilateral cortical visual impairment with no 
useful vision. *Outcome at 18 months was not available for one infant in the 
group allocated to cooling.
Table 3: Postnatal age at scan, MRI abnormalities, and outcome up to 
18 months of age in cooled and non-cooled infants 
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thalami and the white matter, but the reduction in cortical 
grey matter abnormalities in the cooled compared with 
the non-cooled group was not statistically signiﬁ cant 
(table 2).
Therapeutic hypothermia might alter the prognostic 
evaluation of infants with hypoxic–ischaemic 
encephalopathy.28 Secondary analysis of the Coolcap 
study showed that infants treated with cooling had a 
more favourable prognosis than was suggested by the 
clinical grade of encephalopathy compared with infants 
treated with standard care. Therefore, the prognostic 
value of neuroimaging might be altered after therapeutic 
hypothermia. A comparison of prognostic accuracy 
requires that the tests are compared in the same 
population and is therefore not applicable in our study. 
However, we found that the prediction of the combined 
rates of death and severe disability to 18 months of age by 
MRI was good in cooled and non-cooled infants and was 
similar to that previously reported for infants who 
received standard care without cooling.14,20 
MRI ﬁ ndings after hypoxic–ischaemic encephalopathy 
might be aﬀ ected by the postnatal age at scan. The 
characteristic abnormalities in the grey and white matter 
might not be apparent on conventional T1-weighted or 
T2-weighted imaging until some days after birth, but 
might be seen earlier with diﬀ usion-weighted imaging.29 
We found that infants who were younger than 8 days 
when scanned were more likely to have major MRI 
abnormalities. Possible explanations are that MRI might 
be done earlier in infants with more severe encephalopathy 
to direct clinical care; alternatively, abnormalities detected 
during the ﬁ rst few days after birth might subsequently 
resolve spontaneously. Because we were unable to assess 
which factors, such as illness severity and access to 
scanning, aﬀ ected the timing of MRI scans, it is not 
possible to ascertain from these data the optimum period 
during which conventional MRI should be done after 
hypoxic–ischaemic encephalopathy. Because no 
additional resources for MRI scanning were provided to 
the participating hospitals, our ﬁ nding that MRI at a 
median of 8 days accurately predicted outcome at 
18 months of age in cooled and non-cooled infants is 
likely to be generally applicable. 
These data show that MRI in the neonatal period is 
qualiﬁ ed as a biomarker of disease and treatment 
response and might be of use in other neuroprotective 
studies. 
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